ORG Partners’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

ORG Partners’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11	Closed	-$372	–	1340
2024 Q2	$372	Buy	+11	New	+$369	﹤0.01%	1662
2024 Q1	–	Sell	-11	Closed	-$363	–	976
2023 Q4	$363	Buy	+11	New	+$295	﹤0.01%	1062
2023 Q3	–	Sell	-11	Closed	-$346	–	1561
2023 Q2	$346	Buy	+11	New	+$342	﹤0.01%	1298

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

PWA

Phoenix Wealth Advisors Chapel Hill, North Carolina $253M AUM 17.97% 1-Year Est. Return

ORG Partners's SBIO Position: Q3 2024 in Review

ORG Partners sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2024, closing a stake of 11 shares — an estimated $372 sold.

ORG Partners first reported a position in SBIO in Q2 2023 and held it in 3 quarters. The position peaked at $372 in Q2 2024. 37 funds tracked by Wall St. Rank hold SBIO as of Q3 2024.

ORG Partners reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2024 after selling out during the quarter.
ORG Partners sold 11 ALPS Medical Breakthroughs ETF shares in Q3 2024, an estimated $372.
ORG Partners first reported a position in ALPS Medical Breakthroughs ETF in Q2 2023 and held it in 3 quarters.
ORG Partners's ALPS Medical Breakthroughs ETF position peaked at $372 in Q2 2024.
37 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2024.

Based on ORG Partners's 13F filing for Q3 2024, filed 11 Oct 2024.